Pulse Biosciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.17 |
Market Cap |
$270.68 M |
Shares Outstanding |
20.71 M |
Public Float |
7.92 M |
Address |
3957 Point Eden Way Hayward California 94545 United States |
Employees | - |
Website | http://www.pulsebiosciences.com |
Updated | 07/08/2019 |
Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. |